[Author Disclosure: This content reflects the views of the author and is provided for informational purposes only. It does not constitute investment advice and is not a recommendation or endorsement by BioTech Funding Portal. Any investment decision should be based solely on the issuer’s official offering materials.]
Glafabra co-founder Dr. Jeff Medin presents Live-cel data at IFFD 2026, the international Fabry symposium at Jikei University in Tokyo, on October 2.
This puts trial data in front of the specialist community that diagnoses and manages Fabry patients directly -- a different, and in some ways more demanding, audience than investors or the general public.
We'll report what was actually discussed and asked, not just that the talk happened.
Check back Friday for the debrief.
Follow the whole series: https://bit.ly/Glafabra-TTW
@Brian Christie @Neva West @Brian Christie @Tetsu Yung
Testing the Waters disclosure: We are considering a capital raise and are "Testing the Waters" under Regulation Crowdfunding. No money or other consideration is being solicited, and any that is sent in response will not be accepted. We cannot accept any offer to buy securities, and no part of the purchase price can be received until an offering statement is filed and only through the BioTech Funding Portal platform. Any indication of interest is non-binding and involves no obligation or commitment of any kind.
Register for FREE to comment or continue reading this article. Already registered? Login here.
0